Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient

Epstein–Barr virus (EBV) is known to establish latent infections in B‐lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV‐associated smooth muscle tumors has been reported in transplant recipients. We herein...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant infectious disease 2013-10, Vol.15 (5), p.E182-E186
Hauptverfasser: Conrad, A., Brunet, A.‐S., Hervieu, V., Chauvet, C., Buron, F., Collardeau‐Frachon, S., Rivet, C., Cassier, P., Testelin, S., Lachaux, A., Morelon, E., Thaunat, O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E186
container_issue 5
container_start_page E182
container_title Transplant infectious disease
container_volume 15
creator Conrad, A.
Brunet, A.‐S.
Hervieu, V.
Chauvet, C.
Buron, F.
Collardeau‐Frachon, S.
Rivet, C.
Cassier, P.
Testelin, S.
Lachaux, A.
Morelon, E.
Thaunat, O.
description Epstein–Barr virus (EBV) is known to establish latent infections in B‐lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV‐associated smooth muscle tumors has been reported in transplant recipients. We herein describe 2 new cases of EBV‐associated post‐transplant smooth muscle tumors (EBV‐PTSMT), including the first in a facial composite tissue graft recipient. Among the striking features shared by these 2 patients were their young ages, the fact that they were naïve for EBV before the transplantation, that they developed a post‐transplant lymphoproliferative disorder before the diagnosis of EBV‐PTSMT, and that they responded favorably to reduction of immunosuppression. Radiological and histologic features of EBV‐PTSMT are shown. Finally, pathophysiology and therapeutic management of EBV‐PTSMT are discussed based on a comprehensive review of the literature.
doi_str_mv 10.1111/tid.12126
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1464501619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089706701</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3126-e49e79efc6774e68bae8831ee2d0c7894b28b4c0f6c3c8592429c53d627f35993</originalsourceid><addsrcrecordid>eNqN0c1O3DAQB3CralXowoEXQJZ64RLwVxL7SBdKkZC4wDnyOhMwSuLgcUDc4A0q9Q33SXAX2kNP9cUj-6fRjP6E7HF2yPM5Sr495IKL6gPZ5tKYQrJKfNzUuhCillvkC-IdY7w2ynwmW0IxqQSX2-TldMIEflw___pmY6QPPs64fv5pEYPzNkFLcQgh3dJhRtcDTfMQIlI_UktdGKaAPuVXjzgDtX0fbqLtErVjm8EEbe4RvaO9f4BIU7QjTr0dE43g_ORhTDvkU2d7hN33e0Guv59eLX8UF5dn58vji2KSebMClIHaQOequlZQ6ZUFrSUHEC1ztTZqJfRKOdZVTjpdGqGEcaVsK1F3sjRGLsjBW98phvsZMDWDRwd9ngbCjA1XlSoZr_j_UCUVY4brTL_-Q-_CHMe8SFbSCF1yXWe1_67m1QBtM0U_2PjU_Mkhg6M38Oh7ePr7z1nzO-AmB9xsAm6uzk82hXwFJFuatg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1439285187</pqid></control><display><type>article</type><title>Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Conrad, A. ; Brunet, A.‐S. ; Hervieu, V. ; Chauvet, C. ; Buron, F. ; Collardeau‐Frachon, S. ; Rivet, C. ; Cassier, P. ; Testelin, S. ; Lachaux, A. ; Morelon, E. ; Thaunat, O.</creator><creatorcontrib>Conrad, A. ; Brunet, A.‐S. ; Hervieu, V. ; Chauvet, C. ; Buron, F. ; Collardeau‐Frachon, S. ; Rivet, C. ; Cassier, P. ; Testelin, S. ; Lachaux, A. ; Morelon, E. ; Thaunat, O.</creatorcontrib><description>Epstein–Barr virus (EBV) is known to establish latent infections in B‐lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV‐associated smooth muscle tumors has been reported in transplant recipients. We herein describe 2 new cases of EBV‐associated post‐transplant smooth muscle tumors (EBV‐PTSMT), including the first in a facial composite tissue graft recipient. Among the striking features shared by these 2 patients were their young ages, the fact that they were naïve for EBV before the transplantation, that they developed a post‐transplant lymphoproliferative disorder before the diagnosis of EBV‐PTSMT, and that they responded favorably to reduction of immunosuppression. Radiological and histologic features of EBV‐PTSMT are shown. Finally, pathophysiology and therapeutic management of EBV‐PTSMT are discussed based on a comprehensive review of the literature.</description><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/tid.12126</identifier><identifier>PMID: 24034213</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Adult ; Age ; Allografts ; composite tissue allotransplantation ; Epstein-Barr virus ; Epstein-Barr Virus Infections - diagnosis ; Epstein-Barr Virus Infections - etiology ; Epstein-Barr Virus Infections - therapy ; Epstein-Barr Virus Infections - virology ; face transplantation ; Facial Transplantation - adverse effects ; Female ; Herpesvirus 4, Human - genetics ; Herpesvirus 4, Human - immunology ; Herpesvirus 4, Human - isolation &amp; purification ; Humans ; Immunocompromised Host ; Immunosuppression - adverse effects ; Infant ; Liver Transplantation - adverse effects ; Lymphoma, B-Cell - diagnosis ; Lymphoma, B-Cell - etiology ; Lymphoma, B-Cell - therapy ; Male ; Postoperative Complications - diagnosis ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; post‐transplant lymphoproliferative disorders ; post‐transplant smooth muscle tumors ; PTLD ; Smooth Muscle Tumor - diagnosis ; Smooth Muscle Tumor - etiology ; Smooth Muscle Tumor - therapy ; Smooth Muscle Tumor - virology</subject><ispartof>Transplant infectious disease, 2013-10, Vol.15 (5), p.E182-E186</ispartof><rights>2013 John Wiley &amp; Sons A/S</rights><rights>2013 John Wiley &amp; Sons A/S.</rights><rights>2013 Wiley Periodicals, Inc</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftid.12126$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftid.12126$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24034213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conrad, A.</creatorcontrib><creatorcontrib>Brunet, A.‐S.</creatorcontrib><creatorcontrib>Hervieu, V.</creatorcontrib><creatorcontrib>Chauvet, C.</creatorcontrib><creatorcontrib>Buron, F.</creatorcontrib><creatorcontrib>Collardeau‐Frachon, S.</creatorcontrib><creatorcontrib>Rivet, C.</creatorcontrib><creatorcontrib>Cassier, P.</creatorcontrib><creatorcontrib>Testelin, S.</creatorcontrib><creatorcontrib>Lachaux, A.</creatorcontrib><creatorcontrib>Morelon, E.</creatorcontrib><creatorcontrib>Thaunat, O.</creatorcontrib><title>Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><description>Epstein–Barr virus (EBV) is known to establish latent infections in B‐lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV‐associated smooth muscle tumors has been reported in transplant recipients. We herein describe 2 new cases of EBV‐associated post‐transplant smooth muscle tumors (EBV‐PTSMT), including the first in a facial composite tissue graft recipient. Among the striking features shared by these 2 patients were their young ages, the fact that they were naïve for EBV before the transplantation, that they developed a post‐transplant lymphoproliferative disorder before the diagnosis of EBV‐PTSMT, and that they responded favorably to reduction of immunosuppression. Radiological and histologic features of EBV‐PTSMT are shown. Finally, pathophysiology and therapeutic management of EBV‐PTSMT are discussed based on a comprehensive review of the literature.</description><subject>Adult</subject><subject>Age</subject><subject>Allografts</subject><subject>composite tissue allotransplantation</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - diagnosis</subject><subject>Epstein-Barr Virus Infections - etiology</subject><subject>Epstein-Barr Virus Infections - therapy</subject><subject>Epstein-Barr Virus Infections - virology</subject><subject>face transplantation</subject><subject>Facial Transplantation - adverse effects</subject><subject>Female</subject><subject>Herpesvirus 4, Human - genetics</subject><subject>Herpesvirus 4, Human - immunology</subject><subject>Herpesvirus 4, Human - isolation &amp; purification</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunosuppression - adverse effects</subject><subject>Infant</subject><subject>Liver Transplantation - adverse effects</subject><subject>Lymphoma, B-Cell - diagnosis</subject><subject>Lymphoma, B-Cell - etiology</subject><subject>Lymphoma, B-Cell - therapy</subject><subject>Male</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>post‐transplant lymphoproliferative disorders</subject><subject>post‐transplant smooth muscle tumors</subject><subject>PTLD</subject><subject>Smooth Muscle Tumor - diagnosis</subject><subject>Smooth Muscle Tumor - etiology</subject><subject>Smooth Muscle Tumor - therapy</subject><subject>Smooth Muscle Tumor - virology</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0c1O3DAQB3CralXowoEXQJZ64RLwVxL7SBdKkZC4wDnyOhMwSuLgcUDc4A0q9Q33SXAX2kNP9cUj-6fRjP6E7HF2yPM5Sr495IKL6gPZ5tKYQrJKfNzUuhCillvkC-IdY7w2ynwmW0IxqQSX2-TldMIEflw___pmY6QPPs64fv5pEYPzNkFLcQgh3dJhRtcDTfMQIlI_UktdGKaAPuVXjzgDtX0fbqLtErVjm8EEbe4RvaO9f4BIU7QjTr0dE43g_ORhTDvkU2d7hN33e0Guv59eLX8UF5dn58vji2KSebMClIHaQOequlZQ6ZUFrSUHEC1ztTZqJfRKOdZVTjpdGqGEcaVsK1F3sjRGLsjBW98phvsZMDWDRwd9ngbCjA1XlSoZr_j_UCUVY4brTL_-Q-_CHMe8SFbSCF1yXWe1_67m1QBtM0U_2PjU_Mkhg6M38Oh7ePr7z1nzO-AmB9xsAm6uzk82hXwFJFuatg</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Conrad, A.</creator><creator>Brunet, A.‐S.</creator><creator>Hervieu, V.</creator><creator>Chauvet, C.</creator><creator>Buron, F.</creator><creator>Collardeau‐Frachon, S.</creator><creator>Rivet, C.</creator><creator>Cassier, P.</creator><creator>Testelin, S.</creator><creator>Lachaux, A.</creator><creator>Morelon, E.</creator><creator>Thaunat, O.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201310</creationdate><title>Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient</title><author>Conrad, A. ; Brunet, A.‐S. ; Hervieu, V. ; Chauvet, C. ; Buron, F. ; Collardeau‐Frachon, S. ; Rivet, C. ; Cassier, P. ; Testelin, S. ; Lachaux, A. ; Morelon, E. ; Thaunat, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3126-e49e79efc6774e68bae8831ee2d0c7894b28b4c0f6c3c8592429c53d627f35993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Age</topic><topic>Allografts</topic><topic>composite tissue allotransplantation</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - diagnosis</topic><topic>Epstein-Barr Virus Infections - etiology</topic><topic>Epstein-Barr Virus Infections - therapy</topic><topic>Epstein-Barr Virus Infections - virology</topic><topic>face transplantation</topic><topic>Facial Transplantation - adverse effects</topic><topic>Female</topic><topic>Herpesvirus 4, Human - genetics</topic><topic>Herpesvirus 4, Human - immunology</topic><topic>Herpesvirus 4, Human - isolation &amp; purification</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunosuppression - adverse effects</topic><topic>Infant</topic><topic>Liver Transplantation - adverse effects</topic><topic>Lymphoma, B-Cell - diagnosis</topic><topic>Lymphoma, B-Cell - etiology</topic><topic>Lymphoma, B-Cell - therapy</topic><topic>Male</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>post‐transplant lymphoproliferative disorders</topic><topic>post‐transplant smooth muscle tumors</topic><topic>PTLD</topic><topic>Smooth Muscle Tumor - diagnosis</topic><topic>Smooth Muscle Tumor - etiology</topic><topic>Smooth Muscle Tumor - therapy</topic><topic>Smooth Muscle Tumor - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conrad, A.</creatorcontrib><creatorcontrib>Brunet, A.‐S.</creatorcontrib><creatorcontrib>Hervieu, V.</creatorcontrib><creatorcontrib>Chauvet, C.</creatorcontrib><creatorcontrib>Buron, F.</creatorcontrib><creatorcontrib>Collardeau‐Frachon, S.</creatorcontrib><creatorcontrib>Rivet, C.</creatorcontrib><creatorcontrib>Cassier, P.</creatorcontrib><creatorcontrib>Testelin, S.</creatorcontrib><creatorcontrib>Lachaux, A.</creatorcontrib><creatorcontrib>Morelon, E.</creatorcontrib><creatorcontrib>Thaunat, O.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conrad, A.</au><au>Brunet, A.‐S.</au><au>Hervieu, V.</au><au>Chauvet, C.</au><au>Buron, F.</au><au>Collardeau‐Frachon, S.</au><au>Rivet, C.</au><au>Cassier, P.</au><au>Testelin, S.</au><au>Lachaux, A.</au><au>Morelon, E.</au><au>Thaunat, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2013-10</date><risdate>2013</risdate><volume>15</volume><issue>5</issue><spage>E182</spage><epage>E186</epage><pages>E182-E186</pages><issn>1398-2273</issn><eissn>1399-3062</eissn><abstract>Epstein–Barr virus (EBV) is known to establish latent infections in B‐lymphocytes that can cause lymphoproliferative disorders particularly in immunocompromised patients. More recently, the development of rare EBV‐associated smooth muscle tumors has been reported in transplant recipients. We herein describe 2 new cases of EBV‐associated post‐transplant smooth muscle tumors (EBV‐PTSMT), including the first in a facial composite tissue graft recipient. Among the striking features shared by these 2 patients were their young ages, the fact that they were naïve for EBV before the transplantation, that they developed a post‐transplant lymphoproliferative disorder before the diagnosis of EBV‐PTSMT, and that they responded favorably to reduction of immunosuppression. Radiological and histologic features of EBV‐PTSMT are shown. Finally, pathophysiology and therapeutic management of EBV‐PTSMT are discussed based on a comprehensive review of the literature.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>24034213</pmid><doi>10.1111/tid.12126</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1398-2273
ispartof Transplant infectious disease, 2013-10, Vol.15 (5), p.E182-E186
issn 1398-2273
1399-3062
language eng
recordid cdi_proquest_miscellaneous_1464501619
source MEDLINE; Wiley Journals
subjects Adult
Age
Allografts
composite tissue allotransplantation
Epstein-Barr virus
Epstein-Barr Virus Infections - diagnosis
Epstein-Barr Virus Infections - etiology
Epstein-Barr Virus Infections - therapy
Epstein-Barr Virus Infections - virology
face transplantation
Facial Transplantation - adverse effects
Female
Herpesvirus 4, Human - genetics
Herpesvirus 4, Human - immunology
Herpesvirus 4, Human - isolation & purification
Humans
Immunocompromised Host
Immunosuppression - adverse effects
Infant
Liver Transplantation - adverse effects
Lymphoma, B-Cell - diagnosis
Lymphoma, B-Cell - etiology
Lymphoma, B-Cell - therapy
Male
Postoperative Complications - diagnosis
Postoperative Complications - etiology
Postoperative Complications - therapy
post‐transplant lymphoproliferative disorders
post‐transplant smooth muscle tumors
PTLD
Smooth Muscle Tumor - diagnosis
Smooth Muscle Tumor - etiology
Smooth Muscle Tumor - therapy
Smooth Muscle Tumor - virology
title Epstein–Barr virus‐associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A37%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epstein%E2%80%93Barr%20virus%E2%80%90associated%20smooth%20muscle%20tumors%20in%20a%20composite%20tissue%20allograft%20and%20a%20pediatric%20liver%20transplant%20recipient&rft.jtitle=Transplant%20infectious%20disease&rft.au=Conrad,%20A.&rft.date=2013-10&rft.volume=15&rft.issue=5&rft.spage=E182&rft.epage=E186&rft.pages=E182-E186&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/tid.12126&rft_dat=%3Cproquest_pubme%3E3089706701%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1439285187&rft_id=info:pmid/24034213&rfr_iscdi=true